Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | phentolamine | 5775 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | phentolamine | 5775 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | phentolamine | 5775 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | minocycline | 54675783 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | minocycline | 54675783 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | minocycline | 54675783 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | tyrphostin AG-1478 | 2051 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | tyrphostin AG-1478 | 2051 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | tyrphostin AG-1478 | 2051 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | tyrphostin AG-1478 | 2051 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | tyrphostin AG-1478 | 2051 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | MG-132 | 689043 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | MG-132 | 689043 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | MG-132 | 689043 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | MG-132 | 689043 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | MG-132 | 689043 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | MG-132 | 689043 | drug-path |
| Asthma | R-HSA-444620 | map05310 | MG-132 | 689043 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | MG-132 | 689043 | drug-path |
| Shigellosis | 0 | map05131 | cimetidine | 2756 | drug-path |